A MAJOR PLAYER IN THE BIO-PHARMACEUTICAL INDUSTRY IN NEW MEXICO HAS A NEW OWNER. OSO-BIO HAS AGREED TO BE PURCHASED BY ALBANY MOLECULAR RESEARCH FOR 110-MILLION DOLLARS IN CASH.
ALBUQUERQUE BUSINESS FIRST SAYS OSO-BIO HAS 350 EMPLOYEES AND IS THE STATE'S 14TH LARGEST PRIVATE COMPANY. THE COMPANY PROVIDES INJECTABLE STERILE LIQUIDS FOR CLINICAL PRODUCTS AND TRIALS.
